Related Stories
Progress
For Sopharma AD this effort is another contribution to an excellent corporate governance file.
Business & Markets
When financial information becomes an opportunity for futures analysts.
Corporate News
Financial News
2 April 2021
Notification on the adoption of a decision for amendments to the Articles of Association of the Company
26 March 2021
Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)
Financial Highlights 31 December, 2020
1,439,879
BGN '000 Revenue
90,607
BGN '000 EBITDA
44,000
BGN '000 Revenue from operating profit
19,977
BGN '000 Net profit for the year
0.199
BGN Earnings per share
Next events
Equity story
85+ year track record in the pharma industry
Leadership
Growth
Portfolio
Profitability
Business Model
M&A